{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:31:57Z","timestamp":1792513917295,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.copbio.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T17:46:34Z","timestamp":1486489594000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Advances in the clinical translation of nanotechnology"],"prefix":"10.1016","volume":"46","author":[{"given":"David A","family":"Scheinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan P","family":"Stater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.copbio.2017.01.002_sbref0005","doi-asserted-by":"crossref","first-page":"331ra39","DOI":"10.1126\/scitranslmed.aac9647","article-title":"Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury","volume":"8","author":"Alidori","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.copbio.2017.01.002_bib0010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.copbio.2017.01.002_bib0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semradonc.2010.10.003","article-title":"Will nanotechnology influence targeted cancer therapy?","volume":"21","author":"Grimm","year":"2011","journal-title":"Semin Radiat Oncol"},{"issue":"January (1)","key":"10.1016\/j.copbio.2017.01.002_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.copbio.2017.01.002_bib0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrclinonc.2010.38","article-title":"Conscripts of the infinite armada: systemic cancer therapy using nanomaterials","volume":"7","author":"Scheinberg","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.copbio.2017.01.002_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21070867","article-title":"Advanced nanobiomaterials: vaccines, diagnosis and treatment of infectious diseases","volume":"21","author":"Torres-Sangiao","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.copbio.2017.01.002_bib0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2012.09.038","article-title":"Cancer nanomedicines: so many papers and so few drugs!","volume":"65","author":"Venditto","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.copbio.2017.01.002_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1148\/radiol.14131520","article-title":"Nanoparticles for imaging: top or flop?","volume":"273","author":"Kiessling","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.copbio.2017.01.002_bib0045","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1039\/C2CS15261D","article-title":"Multifunctional nanoparticles for multimodal imaging and theragnosis","volume":"41","author":"Lee","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.copbio.2017.01.002_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.copbio.2017.01.002_bib0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nmat1571","article-title":"An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles","volume":"5","author":"Rabin","year":"2006","journal-title":"Nat Mater"},{"key":"10.1016\/j.copbio.2017.01.002_bib0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/138920112799436339","article-title":"Enzymatically activatable diagnostic probes","volume":"13","author":"Thorek","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.copbio.2017.01.002_bib0065","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/nm.3323","article-title":"Quantitative imaging of disease signatures through radioactive decay signal conversion","volume":"19","author":"Thorek","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.copbio.2017.01.002_bib0070","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/jmri.24691","article-title":"Emerging applications for ferumoxytol as a contrast agent in MRI","volume":"41","author":"Bashir","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.copbio.2017.01.002_bib0075","doi-asserted-by":"crossref","first-page":"260ra149","DOI":"10.1126\/scitranslmed.3009524","article-title":"Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe","volume":"6","author":"Phillips","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.copbio.2017.01.002_bib0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fphar.2015.00197","article-title":"Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery","volume":"6","author":"Paefgen","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.copbio.2017.01.002_bib0085","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2009.05.010","article-title":"Diagnostic nanocarriers for sentinel lymph node imaging","volume":"138","author":"Jain","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.copbio.2017.01.002_sbref0090","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat Mater"},{"key":"10.1016\/j.copbio.2017.01.002_bib0095","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1021\/acs.chemmater.5b01222","article-title":"Control of ultrasmall sub-10nm ligand-functionalized fluorescent core\u2013shell silica nanoparticle growth in water","volume":"27","author":"Ma","year":"2015","journal-title":"Chem Mater"},{"key":"10.1016\/j.copbio.2017.01.002_bib0100","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1586\/14737140.2015.1086647","article-title":"Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects","volume":"15","author":"Alphandery","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.copbio.2017.01.002_bib0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3322\/caac.21199","article-title":"Nanooncology: the future of cancer diagnosis and therapy","volume":"63","author":"Thakor","year":"2013","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.copbio.2017.01.002_bib0110","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/S0140-6736(14)61457-4","article-title":"Cancer nanomedicines: closing the translational gap","volume":"384","author":"Gabizon","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.copbio.2017.01.002_bib0115","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.2174\/0929867321666140716101921","article-title":"Challenges in the design of clinically useful brain-targeted drug nanocarriers","volume":"21","author":"Costantino","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.copbio.2017.01.002_bib0120","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1016\/j.bmc.2015.09.050","article-title":"Ultrasmall dual-modality silica nanoparticle drug conjugates: design, synthesis, and characterization","volume":"23","author":"Yoo","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.copbio.2017.01.002_sbref0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jconrel.2014.05.002","article-title":"Stimuli-sensitive nanopreparations for combination cancer therapy","volume":"190","author":"Jhaveri","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.copbio.2017.01.002_bib0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.10.019","article-title":"Combo nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy","volume":"98","author":"Kemp","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.copbio.2017.01.002_bib0135","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1021\/nn4047925","article-title":"Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment","volume":"7","author":"Deng","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.copbio.2017.01.002_bib0140","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.copbio.2017.01.002_bib0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature07758","article-title":"The promises and pitfalls of RNA-interference-based therapeutics","volume":"457","author":"Castanotto","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.copbio.2017.01.002_bib0150","first-page":"22","article-title":"There\u2019s plenty of room at the bottom","volume":"23","author":"Feynman","year":"1960","journal-title":"Eng Sci"},{"key":"10.1016\/j.copbio.2017.01.002_bib0155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.copbio.2017.01.002_bib0160","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.copbio.2017.01.002_bib0165","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1126\/science.1252967","article-title":"RNA interference. Drugging RNAi","volume":"347","author":"Haussecker","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.copbio.2017.01.002_bib0170","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/mt.2011.294","article-title":"Action and reaction: the biological response to siRNA and its delivery vehicles","volume":"20","author":"Kanasty","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.copbio.2017.01.002_bib0175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.copbio.2017.01.002_sbref0180","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat Mater"},{"key":"10.1016\/j.copbio.2017.01.002_bib0185","doi-asserted-by":"crossref","first-page":"12343","DOI":"10.1038\/ncomms12343","article-title":"Deconvoluting hepatic processing of carbon nanotubes","volume":"7","author":"Alidori","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2017.01.002_bib0190","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1021\/nl504482t","article-title":"Ultrasensitive silicon nanowire for real-world gas sensing: noninvasive diagnosis of cancer from breath volatolome","volume":"15","author":"Shehada","year":"2015","journal-title":"Nano Lett"},{"key":"10.1016\/j.copbio.2017.01.002_bib0195","unstructured":"ClinicalTrials.gov 2016. Available from: https:\/\/clinicaltrials.gov\/. [cited 15 August 2016]."},{"key":"10.1016\/j.copbio.2017.01.002_bib0200","doi-asserted-by":"crossref","first-page":"17104","DOI":"10.1073\/pnas.1418637111","article-title":"NanoFlares for the detection, isolation, and culture of live tumor cells from human blood","volume":"111","author":"Halo","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"September (5)","key":"10.1016\/j.copbio.2017.01.002_bib0205","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/adhm.201600328","article-title":"MicroRNA-responsive drug release system for selective fluorescence imaging and photodynamic therapy in vivo","volume":"18","author":"Lee","year":"2016","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.copbio.2017.01.002_bib0210","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1021\/acs.analchem.6b01597","article-title":"Surface-enhanced Raman spectroscopy biosensing: in vivo diagnostics and multimodal imaging","volume":"88","author":"Henry","year":"2016","journal-title":"Anal Chem"},{"key":"10.1016\/j.copbio.2017.01.002_bib0215","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1021\/nl503997m","article-title":"Biodegradable elastomers and silicon nanomembranes\/nanoribbons for stretchable, transient electronics, and biosensors","volume":"15","author":"Hwang","year":"2015","journal-title":"Nano Lett"},{"key":"10.1016\/j.copbio.2017.01.002_bib0220","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1021\/ja505529n","article-title":"Helical polycarbodiimide cloaking of carbon nanotubes enables inter-nanotube exciton energy transfer modulation","volume":"136","author":"Budhathoki-Uprety","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.copbio.2017.01.002_bib0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/acsnano.5b05438","article-title":"Cell membrane proteins modulate the carbon nanotube optical bandgap via surface charge accumulation","volume":"10","author":"Roxbury","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.copbio.2017.01.002_bib0230","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nnano.2013.222","article-title":"In vivo biosensing via tissue-localizable near-infrared-fluorescent single-walled carbon nanotubes","volume":"8","author":"Iverson","year":"2013","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.copbio.2017.01.002_bib0235","doi-asserted-by":"crossref","DOI":"10.3402\/nano.v1i0.4889","article-title":"Gold nanoparticles delivery in mammalian live cells: a critical review","volume":"1","author":"Levy","year":"2010","journal-title":"Nano Rev"},{"key":"10.1016\/j.copbio.2017.01.002_bib0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/mt.2012.185","article-title":"The possible proton sponge effect of polyethylenimine (PEI) does not include change in lysosomal pH","volume":"21","author":"Benjaminsen","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.copbio.2017.01.002_bib0245","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/anie.201207664","article-title":"Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization","volume":"52","author":"Ali-Boucetta","year":"2013","journal-title":"Angew Chem"},{"key":"10.1016\/j.copbio.2017.01.002_bib0250","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.addr.2013.07.019","article-title":"Determinants of carbon nanotube toxicity","volume":"65","author":"Lanone","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.copbio.2017.01.002_bib0255","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s11051-010-9911-8","article-title":"Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?","volume":"12","author":"Alkilany","year":"2010","journal-title":"J Nanopart Res"},{"issue":"October (33)","key":"10.1016\/j.copbio.2017.01.002_bib0260","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"10","author":"Bobo","year":"2016","journal-title":"Pharm Res"},{"issue":"January (9)","key":"10.1016\/j.copbio.2017.01.002_bib0265","article-title":"Investigational nanomedicines in a review of nanotherapeutics currently undergoing clinical trials","volume":"1","author":"Caster","year":"2017","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.copbio.2017.01.002_bib0270","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2147\/IJN.S102385","article-title":"A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements","volume":"11","author":"Giannakou","year":"2016","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.copbio.2017.01.002_bib0275","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7150\/thno.14203","article-title":"DNA nanotechnology for cancer therapy","volume":"6","author":"Kumar","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.copbio.2017.01.002_bib0280","doi-asserted-by":"crossref","first-page":"345ra87","DOI":"10.1126\/scitranslmed.aaf7374","article-title":"P-selectin is a nanotherapeutic delivery target in the tumor microenvironment","volume":"8","author":"Shamay","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.copbio.2017.01.002_bib0285","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166916302221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166916302221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T08:58:09Z","timestamp":1760691489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166916302221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":57,"alternative-id":["S0958166916302221"],"URL":"https:\/\/doi.org\/10.1016\/j.copbio.2017.01.002","relation":{},"ISSN":["0958-1669"],"issn-type":[{"value":"0958-1669","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the clinical translation of nanotechnology","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.copbio.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}